AC Immune SA

Follow
Verify
From Verify.Wiki
Jump to: navigation, search
Aci.png
www.acimmune.com
AC Immune SA
Type Public
Industry Biotechnology
Founded 2003
Headquarters Lausanne, Switzerland
Key people Andrea Pfeifer (Co-Founder & CEO), Jean-Fabien Monin (CFO), Andreas Muhs (CSO) [1]
Investors Dietmar Hopp
Number of employees 62 [2]

AC Immune SA, a clinical stage Swiss-based biopharmaceutical company, focuses on neurodegenerative diseases with three product candidates in clinical trials. It designs, discovers, and develops therapeutic and diagnostic products intended to prevent and modify diseases caused by misfolding proteins. The company’s technology platforms create antibodies, small molecules, and vaccines to address a broad spectrum of neurodegenerative indications. It offers its therapies to address Alzheimer disease and neurodegenerative diseases, such as Parkinson’s, Down syndrome, and glaucoma.
AC Immune SA was founded in 2003 and is based in Lausanne, Switzerland. [3]

History

Controversies

Top 5 Recent Tweets

DateAuthorComment
July 12, 2018bibeypost_stockIs AC Immune SA $ACIU's Fuel Running Low? The Stock Reaches 52-Week High Today - https://t.co/IEdpuynxz5
July 12, 2018reurope_stockCould AC Immune SA $ACIU Skyrocket Even More? The Stock Just Made 52-Week High https://t.co/qaR7JUidCV
July 12, 2018The_CasualSmartWhat's Next for AC Immune SA $ACIU After Reaching 52-Week High? https://t.co/Q9aivwrlM2


Top 5 Recent News Headlines

Top 5 Lifetime Tweets

Top 5 Lifetime News Headlines

  1. http://www.acimmune.com/en/senior-management-team/
  2. http://www.nasdaq.com/markets/ipos/company/ac-immune-sa-995734-81000
  3. http://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=22309440

Verification history